Genentech Was Too Slow In Trying To Halt Amgen's Herceptin Biosimilar Launch

 
• By Brenda Sandburg
  
Lady justice on top of a snail - Illustration
Genentech delayed seeking a preliminary injunction to halt Hercpetin biosimilar launch.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics